<?xml version="1.0"?>
<oembed><version>1.0</version><provider_name>Site da Brakke Consulting</provider_name><provider_url>https://brakkeconsulting.com/pt</provider_url><title>News from Brakke Consulting</title><type>rich</type><width>600</width><height>338</height><html>&lt;blockquote class="wp-embedded-content" data-secret="GMepVAskYB"&gt;&lt;a href="https://brakkeconsulting.com/pt/20066/"&gt;Not&#xED;cias e notas de sa&#xFA;de animal de 3 de outubro de 2003&lt;/a&gt;&lt;/blockquote&gt;&lt;iframe sandbox="allow-scripts" security="restricted" src="https://brakkeconsulting.com/pt/20066/embed/#?secret=GMepVAskYB" width="600" height="338" title="&#x201C;Animal Health News &amp; Notes for October 3, 2003&#x201D; &#x2014; Brakke Consulting Website" data-secret="GMepVAskYB" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"&gt;&lt;/iframe&gt;&lt;script type="text/javascript"&gt;
/* &lt;![CDATA[ */
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&amp;&amp;d.addEventListener&amp;&amp;"undefined"!=typeof URL&amp;&amp;(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&amp;&amp;!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i&lt;o.length;i++)o[i].style.display="none";for(i=0;i&lt;a.length;i++)s=a[i],e.source===s.contentWindow&amp;&amp;(s.removeAttribute("style"),"height"===t.message?(1e3&lt;(r=parseInt(t.value,10))?r=1e3:~~r&lt;200&amp;&amp;(r=200),s.height=r):"link"===t.message&amp;&amp;(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&amp;&amp;n.host===r.host&amp;&amp;l.activeElement===s&amp;&amp;(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r&lt;s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
//# sourceURL=https://brakkeconsulting.com/wp-includes/js/wp-embed.min.js
/* ]]&gt; */
&lt;/script&gt;</html><description>****************************************************************** Brakke Consulting&rsquo;s Animal Health News &amp; Notes for October 3, 2003 Copyright &copy; Brakke Consulting, Inc. ****************************************************************** You can now use this section to jump directly to a news item about a particular company.&nbsp; Simply click on the company name. To return to the top of the newsletter, use the scroll button on the right of your email window. &nbsp; JUMP TO: Farnam First Priority (copper naphthenate) First Priority (pyrantel) Fort Dodge Heska Lallemand Phoenix Scientific Veterinary Products Laboratories Veterinary Laboratories V&#xE9;toquinol &nbsp; ******************************************************************** COMPANY NEWS RELEASES &gt;&nbsp; The FDA amended the animal drug regulations to reflect approval of an abbreviated new animal drug application (ANADA) filed by Heska Corp. The ANADA provides for use of chewable tablets containing ivermectin and pyrantel pamoate for prevention of heartworm disease and for treatment and control of certain gastrointestinal parasites in dogs. (AnimalNet &ndash; Federal Register) &gt;&nbsp;&nbsp; The FDA amended the animal drug regulations to reflect approval of an abbreviated new animal drug application (ANADA) filed by First Priority, Inc. The ANADA provides for oral use of two strengths of pyrantel pamoate suspension in dogs for the management of various internal parasites. (AnimalNet &ndash; Federal Register) &gt;&nbsp; The FDA amended the animal drug regulations to reflect approval of an abbreviated new animal drug application (ANADA) filed by First Priority, Inc. The ANADAView Full Post;</description></oembed>
